Intellia Therapeutics, Inc. · 5 days ago
Senior Manager, Commercial Accounting
Cambridge, MA
Full-time
Hybrid
Senior Level
$143K/yr - $175K/yr
6+ years expIntellia Therapeutics, Inc. is dedicated to developing curative genome editing treatments for severe diseases. They are seeking a Senior Manager, Commercial Accounting to support the transition to a commercial organization by establishing order-to-cash processes and ensuring compliance with regulatory requirements.
BiotechnologyGeneticsHealth CareMedicalTherapeutics
Responsibilities
Participate in and lead certain pre-launch commercial readiness initiatives
Establish and maintain robust accounting and operating procedures and internal control environment over the revenue cycle to ensure compliance with Sarbanes-Oxley (SOX) Section 404
Partner with internal stakeholders and third-party logistics (3PL) providers, specialty distributors (SDs), and specialty pharmacies (SPs) to design and implement order-to-cash processes and systems to support order-to-cash transactional reporting, ensuring seamless integration between ERP system and logistics providers
Lead implementation and ongoing management of government pricing / gross-to-net (GTN) system to support GTN accounting, reporting and compliance
Build and manage complex GTN models to estimate deductions, including statutory rebates (Medicaid, 340B) and value-based arrangements
Oversee the processing of customer receipts, ensuring accurate application of payments and manage payment processing for distribution channel partners, validating service fees and prompt-pay discounts
Lead the monthly, quarterly, and year-end financial close for commercial revenue, including journal entries, account reconciliations and disclosures for AR, deferred revenue, and rebate accruals
Support internal and external auditors in their annual audit, quarterly review, and SOX review procedures
Perform flux analysis and provide insights on revenue trends, variances, and GTN adjustments for senior leadership
Cross-functional collaboration with various commercial, market access, legal, and FP&A stakeholders on contracts, pricing, revenue recognition, sales and rebate forecasting
Identify opportunities to continuously improve processes in order to maximize efficiency and operational excellence
Qualification
Required
Strong technical accounting background and understanding of U.S. GAAP
Detail-oriented, organized, self-motivated with a commitment to high standards for accuracy and integrity
Strong work ethic and ability to manage competing deadlines and priorities in a fast-paced, dynamic environment
Intellectual curiosity and analytical skills with the ability to problem solve with minimal oversight
Advanced knowledge of the U.S. healthcare reimbursement and distribution-channel landscape within the biotechnology industry
Strong interpersonal, written and verbal communications skills to interact across all levels of the organization
Ability to identify and implement improvement opportunities and inspires other team members to do the same; works towards goal achievement and continuous improvement
Bachelor's degree in accounting or finance
Experience at a publicly-traded commercial company within the biotechnology / life sciences industry is required
At least 6-8 years of experience, with a heavy emphasis on the biotechnology / life sciences industry
Preferred
Certified Public Accountant (CPA) preferred
Benefits
Performance-based annual cash bonus
New hire equity grant
Eligibility to be considered for annual equity awards
Company
Intellia Therapeutics, Inc.
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
501-1000 employees
H1B Sponsorship
Intellia Therapeutics, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (38)
2023 (63)
2022 (46)
2021 (10)
2020 (6)
Funding
Current Stage
Public CompanyTotal Funding
$1.54BKey Investors
OrbiMed
2022-11-30Post Ipo Equity· $300M
2021-06-30Post Ipo Equity· $690M
2020-11-30Post Ipo Equity· $201M
Leadership Team
John Leonard
President and Chief Executive Officer, Member Board of Directors
Edward Dulac
Chief Financial Officer
Recent News
Labiotech UG
2026-01-22
Clinical Trials Arena
2026-01-16
Company data provided by crunchbase